Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies

被引：0
|
作者：
P Hamberg
N Steeghs
W J Loos
D van de Biessen
M den Hollander
M Tascilar
J Verweij
H Gelderblom
S Sleijfer
机构：
[1] Erasmus University Medical Center Daniel Den Hoed Cancer Center,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Medical Oncology
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
sunitinib; ifosfamide; pharmacokinetic; VEGF; drug-interaction; phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1706
页数：7
相关论文
共 50 条
  • [1] Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies
    Hamberg, P.
    Steeghs, N.
    Loos, W. J.
    van de Biessen, D.
    den Hollander, M.
    Tascilar, M.
    Verweij, J.
    Gelderblom, H.
    Sleijfer, S.
    BRITISH JOURNAL OF CANCER, 2010, 102 (12) : 1699 - 1706
  • [2] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [3] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [4] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [5] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [6] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study
    Normand Blais
    D. Ross Camidge
    Derek J. Jonker
    Denis Soulières
    Scott A. Laurie
    Sami G. Diab
    Ana Ruiz-Garcia
    Aron Thall
    Ke Zhang
    Richard C. Chao
    Laura Q. Chow
    Investigational New Drugs, 2013, 31 : 1487 - 1498
  • [7] Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    BRITISH JOURNAL OF CANCER, 1998, 77 (01) : 153 - 158
  • [8] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    L. Q. M. Chow
    N. Blais
    D. J. Jonker
    S. A. Laurie
    S. G. Diab
    C. Canil
    M. McWilliam
    A. Thall
    A. Ruiz-Garcia
    K. Zhang
    L. Tye
    R. C. Chao
    D. R. Camidge
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 709 - 722
  • [9] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
    Chow, L. Q. M.
    Blais, N.
    Jonker, D. J.
    Laurie, S. A.
    Diab, S. G.
    Canil, C.
    McWilliam, M.
    Thall, A.
    Ruiz-Garcia, A.
    Zhang, K.
    Tye, L.
    Chao, R. C.
    Camidge, D. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 709 - 722
  • [10] Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study
    Blais, Normand
    Camidge, D. Ross
    Jonker, Derek J.
    Soulieres, Denis
    Laurie, Scott A.
    Diab, Sami G.
    Ruiz-Garcia, Ana
    Thall, Aron
    Zhang, Ke
    Chao, Richard C.
    Chow, Laura Q.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) : 1487 - 1498
12345